<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.TO updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.TO</link>
    <description>q-bio.TO updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.TO" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Thu, 29 May 2025 02:05:46 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Wed, 28 May 2025 00:00:00 -0400</pubDate>
    <skipDays>
      <day>Saturday</day>
      <day>Sunday</day>
    </skipDays>
    <item>
      <title>A Computational Fluid Dynamics study of drug-releasing ocular implants for glaucoma treatment: Comparison of implant size and locations</title>
      <link>https://arxiv.org/abs/2410.01082</link>
      <description>arXiv:2410.01082v2 Announce Type: replace 
Abstract: Drug-releasing implants are gaining momentum in the treatment of glaucoma. Implants present however several limitations. Among these limitations, there is the inability to provide an even distribution of the drug in the trabecular meshwork. CFD simulations were used in this work to study the interplay between ocular fluid dynamics and drug diffusion to explore the options to achieve a homogeneous drug distribution. The analysis finds that the balance between convection and diffusion flux hinders mixing within the eye's anterior chamber. This results in highly localized drug delivery in the trabecular meshwork when using a gravity-driven location implant. The results also show that varying the size of the implant can help to solve the issue. Given the natural variability of the trabecular meshwork size amongst patients, implants with personalized size may become a potential solution. The location of the implant within the eye is also key to effective drug delivery. Natural laminar flow of aqueous humor within the eye's anterior chamber prevents achieving an even drug distribution at the target tissue for gravity-driven location implants. However, the iris-lens gap can be utilized as a natural mixer when placing the implant in the eye's posterior chamber, thus helping with effective delivery.</description>
      <guid isPermaLink="false">oai:arXiv.org:2410.01082v2</guid>
      <category>q-bio.TO</category>
      <pubDate>Wed, 28 May 2025 00:00:00 -0400</pubDate>
      <arxiv:announce_type>replace</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:creator>Daniel Sebastia-Saez, Tao Chen, Cynthia Yu-Wai-Man</dc:creator>
    </item>
  </channel>
</rss>
